SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-286690
Filing Date
2023-12-01
Accepted
2023-12-01 06:06:30
Documents
14
Period of Report
2023-11-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d23829d8k.htm   iXBRL 8-K 24605
2 EX-99.1 d23829dex991.htm EX-99.1 12328
6 GRAPHIC g23829g1201061648661.jpg GRAPHIC 4189
  Complete submission text file 0001193125-23-286690.txt   173396

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bior-20231130.xsd EX-101.SCH 2869
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bior-20231130_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bior-20231130_pre.xml EX-101.PRE 11720
8 EXTRACTED XBRL INSTANCE DOCUMENT d23829d8k_htm.xml XML 3479
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 231457456
SIC: 2834 Pharmaceutical Preparations